Anti-CD16 antibody [EPR22409-124]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
5
(3 Reviews)
|
(19 Publications)
Anti-CD16 antibody [EPR22409-124] (ab246222) is a rabbit monoclonal antibody detecting CD16 in Western Blot, Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
View Alternative Names
CD16b, CD16B, FCG3, FCGR3, IGFR3, FCGR3B, Low affinity immunoglobulin gamma Fc region receptor III-B, Fc-gamma RIII-beta, FcR-10, IgG Fc receptor III-1, CD16-I, Fc-gamma RIII, Fc-gamma RIIIb, FcRIII, FcRIIIb
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD16 antibody [EPR22409-124] (AB246222)
Immunohistochemical analysis of paraffin-embedded human spleen tissue labeling CD16 with ab252905 at 1/500 dilution, followed by Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on red pulp of human spleen (PMID : 26512139; 29692344). Counter stained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 minutes.
The section was incubated with ab252905 for 10 minutes at 37°C. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab187039).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CD16 antibody [EPR22409-124] (AB246222)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized human PBMCs (human peripheral blood mononuclear cells) or Raji (human Burkitt's lymphoma cell line) cell line labeling CD16 with ab246222 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing membranous staining in subsets of human PBMC cells is observed. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).
Secondary antibody only control : Used PBS instead of primary antibody, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
Negative control : Raji (PMID : 11207281).
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-CD16 antibody [EPR22409-124] (AB246222)
Negative control : Raji. (PMID : 11207281).
Raji (human Burkitt's lymphoma cell line) were stained with Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730)(Left) or ab252905 (Right) followed by a Goat anti rabbit IgG (Dylight ® 488) at 1/2000 dilution.
Gated on viable cells.
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD16 antibody [EPR22409-124] (AB246222)
Human PBMCs (human peripheral blood mononuclear cells) were stained with Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (Left) or ab246222 (Right) followed by a Goat anti rabbit IgG (Dylight ® 488) at 1/2000 dilution. They were then stained with Alexa Fluor® 647-conjugated anti-CD14. The expression pattern is consistent with that described in the literature. (PMID : 21738687)
Gated on viable cells.
- IP
Unknown
Immunoprecipitation - Anti-CD16 antibody [EPR22409-124] (AB246222)
CD16 was immunoprecipitated from 0.35 mg of human spleen lysate with ab252905 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab252905 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used as secondary antibody at 1/5000 dilution.
Lane 1 : Human spleen lysate 10 μg (Input).
Lane 2 : ab252905 IP in human spleen lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab252905 in human spleen lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 5 seconds.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab246222).
All lanes:
Immunoprecipitation - Anti-CD16 antibody [EPR22409-124] (ab246222)
Predicted band size: 29 kDa
Observed band size: 50-70 kDa
false
- WB
Unknown
Western blot - Anti-CD16 antibody [EPR22409-124] (AB246222)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure times.
Lane 1 : 92 seconds.
Lanes 2 & 3 : 3 minutes.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 2526846).
Negative control : Raji (PMID : 11207281).
All lanes:
Western blot - Anti-CD16 antibody [EPR22409-124] (ab246222) at 1/1000 dilution
Lane 1:
Human spleen lysate at 20 µg
Lane 2:
Human colon cancer lysate at 20 µg
Lane 3:
Raji (human Burkitt's lymphoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/100000 dilution
Predicted band size: 29 kDa
Observed band size: 50-70 kDa
false
Related conjugates and formulations (6)
-
Anti-CD16 antibody [EPR22409-124] - BSA and Azide free (Detector)
-
Anti-CD16 antibody [EPR22409-124] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD16 antibody [EPR22409-124]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD16 antibody [EPR22409-124]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD16 antibody [EPR22409-124]
-
578 PE
PE Anti-CD16 antibody [EPR22409-124]
Reactivity data
Product details
What is this antibody validated in?
Anti-CD16 antibody [EPR22409-124] (ab246222) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.
What is the molecular weight of CD16?
Anti-CD16 [EPR22409-124] (ab246222) specifically detects a band for CD16 (UniProt: O75015) at a molecular weight of 29kDa.
Trusted by the scientific community
Anti-CD16 [EPR22409-124] (ab246222) was first used in a scientific publication in 2019 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR22409-124] also available for your convenience: ab246222, Carrier free - ab252908, Alexa Fluor® 488 - ab270139, Alexa Fluor® 647 - ab270140
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This receptor plays a significant role in immune system regulation by contributing to the activation of immune effector cells. CD16 is not part of a larger complex but it operates in concert with CD3 proteins to trigger intracellular signaling pathways upon engagement with its ligand. Its function is important for the antibody-dependent clearance of infected or malignant cells from the body representing an essential linkage between innate and adaptive immunity.
Pathways
Signaling involving CD16 is integrated into the immune response mechanisms that include the Fc gamma receptor-mediated phagocytosis pathway. This pathway involves interactions with IgG antibodies and complements the activity of other Fc gamma receptors such as CD32 and CD64. Through these interactions CD16 enhances phagocytic activity and stimulates the secretion of cytokines and chemokines important for orchestrating an effective immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (19)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2406282 PubMed39665236
2024
Applications
Unspecified application
Species
Unspecified reactive species
Immunology 172:469-485 PubMed38544333
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 18:e0295566 PubMed38134018
2023
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 7:135 PubMed38092866
2023
Applications
Unspecified application
Species
Unspecified reactive species
Environmental toxicology 39:1989-2005 PubMed38088504
2023
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:327 PubMed37661226
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed37445610
2023
Applications
Unspecified application
Species
Unspecified reactive species
Folia morphologica : PubMed37183514
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 17:1189348 PubMed37234914
2023
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:44 PubMed36710358
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com